DBVT DBV Technologies S.A.

NASDAQ
$14.02

DBV Technologies S.A. (DBVT) is expected to report earnings on October 15, 2026, after the market close. The consensus earnings estimate is a loss of $0.60 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -11.4% since its last earnings release on July 16, 2026.

DBV Technologies S.A. Missed Consensus Estimates
Thursday, July 16, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 15
Thursday · After Close
Earnings Whisper
-
vs ($0.60)
Rev est $1M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $13.97

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About DBV Technologies S.A.

DBV Technologies SA is an epicutaneous immunotherapy company. The Company is engaged in research and development of patient-friendly therapy for food and pediatric allergy patients.

Sector

Healthcare

Industry

Biotechnology